Public reporting burden for this collection of information is estimated to average 1 hour per response, Including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202. 4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE (DD-MM-YYYY)2. REPORT TYPE 3. DATES COVERED (From -To)
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBERUniversity of Nebraska Medical Center Omaha, NE 68198-5100
SPONSORING I MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S) U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSOR/MONITOR'S REPORT
NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTES
ABSTRACTIn this project we used specifically fluorine labeled photosensitizers which will be of utility in the treatment of breast cancer via photodynamic therapy(PDT). The accumulation of the photosensitizer in the tumor and the muscle were evaluated using noninvasive 19F spectroscopic modality in mice bearing RIF tumor. By determining the relative disposition of the sensitizer we can determine the best time to irradiate the tumor causing minimal damage to nearby healthy cells around the tumor. The absorption, distribution and elimination of the labeled sensitizer were determined using 19F spectroscopy of tumor models after administering a single dose of the sensitizer. The tumor regression was achieved by irradiating the tumor with an appropriate wavelength laser light. The process of tumor regression and the accompanying changes in the high energy phosphates and diffusion process were monitored by 31 P and I H MR studies. The 31 P MR studies performed before and after the use of 19F labeled PS(DOD2,DOD6) showed changes in the spectra and tumor regression was observed after PDT studies under fractionated laser doses. The corresponding nonlabeled compounds showed less significant 31 P spectral changes and lower tumor response following PDT. Soon there after an undergraduate level technician was hired and a year later a graduate level technician was hired to perform higher level data analysis involved in the project. The project did have ups and downs and the initial hurdle was that the 7T magnet could not be charged to the required field strength and hence was maintained at 4.7T while the ...